MNPR Monopar Therapeutics Inc

USD 0.65 -0.01 -1.530071
Icon

Monopar Therapeutics Inc (MNPR) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.65

-0.01 (-1.53)%

USD 0.01B

0.02M

USD 2.00(+207.69%)

N/A

Icon

MNPR

Monopar Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 0.65
0.00 0
Take a Tour

Monopar Therapeutics Inc (MNPR) Stock Forecast

USD 2.00
(+207.69%)

Based on the Monopar Therapeutics Inc stock forecast from 1 analysts, the average analyst target price for Monopar Therapeutics Inc is USD 2.00 over the next 12 months. Monopar Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Monopar Therapeutics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Monopar Therapeutics Inc’s stock price was USD 0.65. Monopar Therapeutics Inc’s stock price has changed by -1.07% over the past week, -4.27% over the past month and -37.50% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...